Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Miagkov

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Arkhiv Anatomii, Gistologii I Embriologii|May 1, 1984
[Relation between the structure of the skate brain and its ecology]N A Miagkov
Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki|January 1, 1975
[Morphology of the brain of the frilled shark]N A Miagkov
Voenno-Meditsinskii Zhurnal|March 4, 2000
[The current diagnosis and treatment of erectile dysfunction]V N Ivanov, Iu A Miagkov, V V Apletaev, et al.
Voenno-Meditsinskii Zhurnal|November 18, 2009
[Penile endoprosthesis in complex rehabilitation of wounded and ill persons with erectile dysfunction]Iu A Miagkov, V N Ivanov, V V Apletaev, et al.
Cellular Immunology|May 3, 2001
Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategyJ M Wu, B Wu, A Miagkov, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Journal of Neuroimmunology|July 10, 2012
Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategyW Sun, R N Adams, A Miagkov, et al.
Journal of Neuroimmunology|August 5, 2008
Granzyme B: evidence for a role in the origin of myasthenia gravisL Casciola-Rosen, A Miagkov, K Nagaraju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Specific immunotherapy by genetically engineered APCs: the "guided missile" strategyB Wu, J M Wu, A Miagkov, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategyD B Drachman, J-M Wu, A Miagkov, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Arkhiv Anatomii, Gistologii I Embriologii|May 1, 1984
[Relation between the structure of the skate brain and its ecology]N A Miagkov
Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki|January 1, 1975
[Morphology of the brain of the frilled shark]N A Miagkov
Voenno-Meditsinskii Zhurnal|March 4, 2000
[The current diagnosis and treatment of erectile dysfunction]V N Ivanov, Iu A Miagkov, V V Apletaev, et al.
Voenno-Meditsinskii Zhurnal|November 18, 2009
[Penile endoprosthesis in complex rehabilitation of wounded and ill persons with erectile dysfunction]Iu A Miagkov, V N Ivanov, V V Apletaev, et al.
Cellular Immunology|May 3, 2001
Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategyJ M Wu, B Wu, A Miagkov, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Journal of Neuroimmunology|July 10, 2012
Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategyW Sun, R N Adams, A Miagkov, et al.
Journal of Neuroimmunology|August 5, 2008
Granzyme B: evidence for a role in the origin of myasthenia gravisL Casciola-Rosen, A Miagkov, K Nagaraju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Specific immunotherapy by genetically engineered APCs: the "guided missile" strategyB Wu, J M Wu, A Miagkov, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategyD B Drachman, J-M Wu, A Miagkov, et al.
Pageof 1